| Technology Name | Tech Id | | Technology Name | Tech Id |
| Cubic Liquid Crystalline Delivery System | DT2004-01 | | Therapeutic for Eosinophilic Disorders (I) | 2008-0110 |
| Diagnostic & Therapeutic for Arthritis | 2001-0808A | | Therapeutic for Eosinophilic Disorders (II) | 2006-0204 |
| Diagnostic & Therapeutic for Eosinophilia (I) | 2003-0612 | | Therapeutic for Eosinophilic Disorders (III) | 1999-0210 |
| Diagnostic & Therapeutic for Eosinophilia (II) | 2004-1003 | | Therapeutic for Eosinophilic Disorders (IV) | 2007-1101 |
| Diagnostic & Therapeutic for Lung Disease (I) | 2004-1102 | | Therapeutic for Hepatic Disorders | 2001-0406 |
| Diagnostic & Therapeutic for Lung Disease (II) | 2002-0227 | | Therapeutic for Infectious and Autoimmune Diseases | 2004-0402 |
| Prevention of Bilirubin Encephalopathy | 2008-0407 | | Therapeutic for Intestinal Anaphylaxis | 2007-1104 |
| Therapeutic for Acute Renal Injury | 2004-0302 | | Therapeutic for Metabolic Diseases | 2002-0717 |
| Therapeutic for Asthma and Allergy | 2002-0924 | | Therapeutic for Neuronal and CNS Disorders | 2005-0406 |
| Therapeutic for Atherosclerosis | 1999-1220 | | Therapeutic for Non-Alcoholic Steotohepatitis | 2005-0504 |
| Therapeutic for Bacterial Infections | 1998-0515 | | Therapeutic for Norovirus Infection (I) | 2005-0302 |
| Therapeutic for Cancer and Vascular Diseases | 2005-0701 | | Therapeutic for Norovirus Infection (II) | 2006-0401 |
| Therapeutic for Cancers (I) | 2004-1104 | | Therapeutic for Pancreatic Cancer | 2006-0908 |
| Therapeutic for Cancers (II) | 2007-0514 | | Therapeutic for Post-MI Tissue Regeneration | 2006-0907 |
| Therapeutic for Cancers (III) | 1998-1117 | | Theraptc Protect. from Diet-Induced Obesity & Insulin Resist. | 2007-0803 |
| Therapeutic for Cardiovascular Disease | 2006-0701 | | Therapeutic for Rotavirus Infection | 1998-0227 |
| Therapeutic for Cartilage Repair | 2001-0911 | | Therapeutic for Spondyloarthritis | 2006-1203 |
